In keeping with this, micromolar affinity CARs with specificity for ICAM-1 or CD38 outperformed their nanomolar counterparts in discriminating between normal and transformed cells, while maintaining strong efficacy against tumour cells [45,46]. This evidence concerns the gene CD38 and neoplasm.